A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects
Status:
Completed
Trial end date:
2016-04-13
Target enrollment:
Participant gender:
Summary
This is a phase 1, non-randomized, fixed sequence, 3-period, drug-drug interaction study to
assess the pharmacokinetics (PK) of AZD7986 in healthy subjects when administered alone and
in combination with multiple doses of verapamil and itraconazole or diltiazem